Total revenue: 1.851
Operating profit: -12.95
Operating profit before tax: -55.608
Total assets: 1.430.020
Total equity: 1.424.547
Currency: NOK (all numbers in thousands)
Management
Board Chairman:
Simen Thorsen
Board Members:
Bente M Søfteland Bøhler
Heidi Sørensen Austbø
Runar Vatne
Sofia Katarina Finneng
Tore Aksel Voldberg
Øystein Arnulf Landvik
General Manager:
Andreas Martinussen
Subsidiary companies:
Largest shareholders:
N/A
KEYWORDS
Biobank, Biotechnology, Health Care, Pharmacological Treatments (New Medicines & Therapies), Terapeutica, Therapeutic agents,